{"id":1835,"date":"2019-09-26T01:04:29","date_gmt":"2019-09-25T23:04:29","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=1835"},"modified":"2025-02-19T09:49:20","modified_gmt":"2025-02-19T08:49:20","slug":"cancer-hereditari","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-cancer\/programa-de-mecanismes-moleculars-i-terapia-experimental-en-oncologia-oncobell\/cancer-hereditari\/","title":{"rendered":"C\u00e0ncer Hereditari"},"content":{"rendered":"\n<h1>\n\t\tC\u00e0ncer hereditari\n\t<\/h1>\n<h3>\n\t\tResum\n\t<\/h3>\n\tSom un grup de recerca multidisciplinar que treballa en C\u00e0ncer Hereditari a l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, Institut de Recerca Biom\u00e8dica de Bellvitge (IDIBELL) i l&#8217;Institut de Recerca en Ci\u00e8ncies de la Salut Germans Trias i Pujol (IGTP). La nostra feina, ja sigui cl\u00ednica o de recerca, se centra en la millora de l&#8217;atenci\u00f3 sanit\u00e0ria dels pacients amb antecedents personals o familiars de c\u00e0ncer.<br \/>\nCom podeu observar a l&#8217;apartat de L\u00ednies de Recerca, l&#8217;objectiu general de la nostra activitat investigadora \u00e9s aprofundir en les bases moleculars del c\u00e0ncer hereditari -amb especial inter\u00e8s en el c\u00e0ncer gastrointestinal, el C\u00e0ncer Hereditari de Mama i Ovari i les s\u00edndromes predisponents a Tumors Rars- per personalitzar la valoraci\u00f3 del risc de pacients i familiars, aix\u00ed com individualitzar la gesti\u00f3 quant a seguiment, tractament i mesures profil\u00e0ctiques i preventives. El grup participa en iniciatives internacionals i nacionals destinades a millorar la classificaci\u00f3 de variants en gens de c\u00e0ncer hereditari, definir guies cl\u00edniques per a pacients amb c\u00e0ncer hereditari i implementar en el Sistema Nacional de Salut la medicina personalitzada basada en la gen\u00f2mica.\n<h2>1243<\/h2>\n<h2>Publicacions<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/04\/114-cancerhereditari-capella-2def_2.jpg\" alt=\"114-cancerhereditari-capella-2def_2\" itemprop=\"image\" height=\"300\" width=\"600\" title=\"114-cancerhereditari-capella-2def_2\" onerror=\"this.style.display='none'\"  \/>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-0\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-0\">L\u00ednies estrat\u00e8giques<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-0\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\t1. Millora de les estrat\u00e8gies de proves gen\u00e8tiques<br \/>\n2. Desenvolupament d&#8217;estrat\u00e8gies per refinar la classificaci\u00f3 de variants en gens de c\u00e0ncer hereditari<br \/>\n3. Personalitzaci\u00f3 dels riscos, la prevenci\u00f3 i el tractament del c\u00e0ncer<br \/>\n4. Identificaci\u00f3 de nous gens i mecanismes implicats en la predisposici\u00f3 al c\u00e0ncer colorectal i poliposi<br \/>\n5. Identificaci\u00f3 de nous gens i mecanismes de s\u00edndromes rars de predisposici\u00f3 a tumors.<br \/>\n6. Establiment, optimitzaci\u00f3 i implementaci\u00f3 de models de darrera generaci\u00f3<br \/>\n7. Identificaci\u00f3 i avaluaci\u00f3 de nous biomarcadors quantitatius (epi)mutacionals en tumors, teixits diana i mostres succed\u00e0nies m\u00ednimament invasives<br \/>\n8. Participaci\u00f3 i lideratge en iniciatives nacionals i regionals de medicina de precisi\u00f3 basada en gen\u00f2mica en c\u00e0ncer<br \/>\n9. Refinament d&#8217;enfocaments terap\u00e8utics per a Neurofibromatosi tipus 1<br \/>\n10. Desenvolupament de recursos de recerca per a pacients, prove\u00efdors d&#8217;atenci\u00f3 m\u00e8dica i investigadors interessats en tumors d&#8217;ovari rars.<br \/>\n11. Refinament de mecanismes moleculars de tumors amb biog\u00e8nesi defectuosa de miARN.\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-1\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-1\">Publicacions seleccionades<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-1\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>Garcia Pelaez,J;Barbosa Matos,R;Lobo,S;Dias,A;Garrido,L;Castedo,S;Sousa,S et al, <strong>Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes<\/strong>, Lancet Oncol., 2023;24(1):91-106, doi:10.1016\/S1470-2045(22)00643-X<\/li>\n<li>Tagliamento,M;Gennari,A;Lambertini,M;Salazar,R;Harbeck,N;Del Mastro,L;Aguilar Company,J et al, <strong>Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer<\/strong>, J. Clin. Oncol., 2023;41(15):2800-2814, doi:10.1200\/JCO.22.01667<\/li>\n<li>VALLE,L;Monahan,KJ, <strong>Genetic predisposition to gastrointestinal polyposis: syndromes, tumour features, genetic testing, and clinical management<\/strong>., Lancet Gastroenterol. Hepatol., 2023;9(1):68-82, doi:10.1016\/S2468-1253(23)00240-6<\/li>\n<li>Tricarico,R;Madzo,J;Scher,G;Cohen,M;Jelinek,J;Maegawa,S;Nagarathinam,R et al, <strong>TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype<\/strong>, Gastroenterology, 2023;164(6):doi:10.1053\/j.gastro.2023.01.039<\/li>\n<li>Capdevila,J;Hernando,J;Teule,A;Lopez,C;Garcia Carbonero,R;Benavent,M;Custodio,A et al, <strong>Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin<\/strong>, Nat. Commun., 2023;14(1):2973-2973, doi:10.1038\/s41467-023-38611-5<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-2\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-2\">Projectes seleccionats<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-2\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\t<ul>\n<li>FIS22096. <strong>Gen\u00f3mica funcional: desarrollo e implementaci\u00f3n de una plataforma para el estudio de casos de c\u00e1ncer hereditario sin resolver<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 3.179.990\u20ac. 2023-2025. PI: LAZARO GARCIA, CONCEPCION.<\/li>\n<li>MCI21007. <strong>Polymerase proofREADing-deficient tumors: genetics and immune biology insights for improved predictive MEDicine<\/strong>. Ministerio de Ciencia e Innovaci\u00f3n. Budget: 393.250\u20ac. 2021-2025. PI: VALLE VELASCO, LAURA.<\/li>\n<li>20MEC021. <strong>Modelando el precancer en la deficiencia reparadora de apareamientos err\u00f3neos germinal para un seguimiento personalizado basado en la respuesta immune<\/strong>. Ministerio de Ciencia e Innovaci\u00f3n. Budget: 338.800\u20ac. 2020-2024. PI: Capell\u00e1 Munar, Gabriel; Marta Pineda.<\/li>\n<li>AEC23003. <strong>DELINEATING THE INVOLVEMENT OF miRNA BIOGENESIS GENES IN TUMOR DEVELOPMENT (miRNAtude)<\/strong>. Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC). Budget: 300.000\u20ac. 2023-2026. PI: RIVERA POLO, BARBARA.<\/li>\n<li>19INT004. <strong>The mechanistic basis for constitutional MLH1 methylation (epimutation)<\/strong>. NATIONAL INSTITUTES OF HEALTH NIH. Budget: 288872,48. 2019-2024. PI: Capell\u00e1 Munar, Gabriel.<\/li>\n<\/ul>\n\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--label-3\" tabindex=\"0\" aria-controls=\"fl-accordion--panel-3\">M\u00e9s informaci\u00f3<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-accordion--icon-3\" tabindex=\"-1\"><i title=\"Expand\">Expand<\/i><\/a>\n\t\t\t\t\t<p><i>Proyectos financiados por el Instituto de Salud Carlos III (ISCIII) y cofinanciados por el Fondo Europeo de Desarrollo Regional (FEDER):<\/i><\/p>\n<p>\u00a0<\/p>\n<p><b>Desarrollo de estrategias terap\u00e9uticas personalizadas para los tumores malignos de las vainas de los nervios perif\u00e9ricos: modelos in vivo y farmacogen\u00f3mica<\/b><\/p>\n<p>PI13\/00285. 01\/2014-06\/2017. 95.500 \u20ac. IP: Concepci\u00f3n L\u00e1zaro Garc\u00eda.<\/p>\n<p>Establecimiento de una plataforma de ensayos terap\u00e9uticos personalizados in vitro e in vivo para los tumores malignos de las vainas de los nervios perif\u00e9ricos (MPNST) e Identificaci\u00f3n de agentes terap\u00e9uticos personalizados para estos tumores hasta llegar a nivel precl\u00ednico. Se prevee que el an\u00e1lisis integrativo de los datos tanto farmacogen\u00f3micos constitucionales como gen\u00f3micos, juntamente con los datos de respuesta a los diferentes tratamientos in vitro e in vivo, ha de permitir disponer de una mejor capacidad predictiva de respuesta utilizando tratamientos personalizados en nuevos casos de MPNST.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/04\/image12.png\" alt=\"\" width=\"249\" height=\"150\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Desarrollo de un sistema no invasivo para el cribado de c\u00e1ncer colorrectal basado en marcadores bacterianos en heces<\/strong><\/p>\nPI: Capell\u00e1 Munar, Gabriel<br \/>\nConvocatoria Retos Colaboraci\u00f3n, expediente: RTC-2016-5017-1<br \/>\nCoordinador: GOODGUT SOCIETAT LIMITADA<br \/>\nMinisterio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI).\n<p>Cofinanciado por el Fondo Europeo de Desarrollo Regional. FEDER, una manera de hacer Europa. Promover el desarrollo tecnol\u00f3gico, la innovaci\u00f3n y una investigaci\u00f3n de calidad).<\/p>\n<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2019\/09\/gobierno-de-espa%C3%B1a-300x63.jpg\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" srcset=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2019\/09\/gobierno-de-espa\u00f1a-300x63.jpg 300w, https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2019\/09\/gobierno-de-espa\u00f1a-768x161.jpg 768w, https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2019\/09\/gobierno-de-espa\u00f1a-1024x214.jpg 1024w\" alt=\"\" width=\"300\" height=\"63\" \/><br \/>\n<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2019\/09\/union-europea-300x78.png\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" srcset=\"https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2019\/09\/union-europea-300x78.png 300w, https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2019\/09\/union-europea-768x200.png 768w, https:\/\/idibell.cat\/es\/wp-content\/uploads\/sites\/4\/2019\/09\/union-europea.png 948w\" alt=\"\" width=\"300\" height=\"78\" \/>\n<p>&nbsp;<\/p>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/10\/Gabriel-Capella22-150x150.jpg\" alt=\"Gabriel-Capell\u00e122\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Gabriel-Capell\u00e122\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tCapell\u00e0 Munar, Gabriel\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:gcapella@idibell.cat\" title=\"gcapella@idibell.cat\"  target=\"_blank\"  rel=\"noopener\">\n\t\tgcapella@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/12\/Conxi-Lazaro-Garcia21-150x150.jpg\" alt=\"Conxi-Lazaro-Garcia21\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Conxi-Lazaro-Garcia21\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tLazaro Garcia, Conxi\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:clazaro@idibell.cat\" title=\"clazaro@idibell.cat\"  target=\"_blank\"  rel=\"noopener\">\n\t\tclazaro@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tInvestigadors principals\n\t<\/h2>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/10\/Gabriel-Capella22-150x150.jpg\" alt=\"Gabriel-Capell\u00e122\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Gabriel-Capell\u00e122\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tCapell\u00e0 Munar, Gabriel\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:gcapella@idibell.cat\" title=\"gcapella@idibell.cat\"  target=\"_blank\"  rel=\"noopener\">\n\t\tgcapella@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/12\/Joan-Maria-Brunet-Vidal21-150x150.jpg\" alt=\"Joan-Maria-Brunet-Vidal21\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Joan-Maria-Brunet-Vidal21\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tBrunet Vidal, Joan Mar\u00eda\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:jbrunet@idibell.cat\" title=\"jbrunet@idibell.cat\"  target=\"_blank\"  rel=\"noopener\">\n\t\tjbrunet@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/12\/Conxi-Lazaro-Garcia21-150x150.jpg\" alt=\"Conxi-Lazaro-Garcia21\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Conxi-Lazaro-Garcia21\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tLazaro Garcia, Conxi\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:clazaro@idibell.cat\" title=\"clazaro@idibell.cat\"  target=\"_blank\"  rel=\"noopener\">\n\t\tclazaro@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/12\/Barbara-Rivera-Polo21-150x150.jpg\" alt=\"Barbara-Rivera-Polo21\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Barbara-Rivera-Polo21\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tRivera Polo, Barbara\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:brivera@idibell.cat\" title=\"brivera@idibell.cat\"  target=\"_blank\"  rel=\"noopener\">\n\t\tbrivera@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/11\/Marta-Pineda22-150x150.jpg\" alt=\"Marta-Pineda22\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Marta-Pineda22\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tPineda Riu, Marta\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:mpinedar@idibell.cat\" title=\"mpinedar@idibell.cat\"  target=\"_blank\"  rel=\"noopener\">\n\t\tmpinedar@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/12\/Laura-Valle-Velasco21-150x150.jpg\" alt=\"Laura-Valle-Velasco21\" itemprop=\"image\" height=\"150\" width=\"150\" title=\"Laura-Valle-Velasco21\" onerror=\"this.style.display='none'\"  \/>\n<h4>\n\t\tValle Velasco, Laura\n\t<\/h4>\n<h4>\n\t\t<a href=\"mailto:lvalle@idibell.cat\" title=\"lvalle@idibell.cat\"  target=\"_blank\"  rel=\"noopener\">\n\t\tlvalle@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\tENLLA\u00c7OS RELACIONATS\n\t<\/h4>\n<h4>\n\t\t<a href=\"https:\/\/hereditarycancergroup.com\/\" title=\"hereditarycancergroup.com\"  target=\"_blank\"  rel=\"noopener\">\n\t\thereditarycancergroup.com\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"https:\/\/raretumorovary.net\/\" title=\"Network of Rare Tumors of the Ovary (NRTO)\"  target=\"_blank\"  rel=\"noopener\">\n\t\tNetwork of Rare Tumors of the Ovary (NRTO)\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"http:\/\/www.lscarisk.org\/\" title=\"Prospective Lynch Syndrome Database (PLSD)\"  target=\"_blank\"  rel=\"noopener\">\n\t\tProspective Lynch Syndrome Database (PLSD)\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"https:\/\/twitter.com\/BRivera_Polo\" title=\"@BRivera_Polo\"  target=\"_blank\"  rel=\"noopener\">\n\t\t@BRivera_Polo\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"https:\/\/twitter.com\/BrunetJbrunet\" title=\"@BrunetJbrunet\"  target=\"_blank\"  rel=\"noopener\">\n\t\t@BrunetJbrunet\n\t\t<\/a>\n\t<\/h4>\n<h4>\n\t\t<a href=\"https:\/\/twitter.com\/LValleResearch\" title=\"@LValleResearch\"  target=\"_blank\"  rel=\"noopener\">\n\t\t@LValleResearch\n\t\t<\/a>\n\t<\/h4>\n<h2>\n\t\tEquip\n\t<\/h2>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-0\" data-index=\"0\" aria-selected=\"true\" aria-controls=\"fl-tabs--panel-0\" aria-expanded=\"true\" role=\"tab\" tabindex=\"0\">\t\t\t\tCaps de grup\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-1\" data-index=\"1\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-1\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tInvestigadors\/es principals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-2\" data-index=\"2\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-2\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tInvestigadors\/es cl\u00ednics\/ques\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-3\" data-index=\"3\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-3\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tInvestigadors\/es postdoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-4\" data-index=\"4\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-4\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tInvestigadors\/es predoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-5\" data-index=\"5\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-5\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tSuport cient\u00edfic\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-6\" data-index=\"6\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-6\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tSuport de gesti\u00f3\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-7\" data-index=\"7\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-7\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tEstudiants\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<a href=\"#\" id=\"fl-tabs--label-8\" data-index=\"8\" aria-selected=\"false\" aria-controls=\"fl-tabs--panel-8\" aria-expanded=\"false\" role=\"tab\" tabindex=\"0\">\t\t\t\tCol\u00b7laboradors\/es\t\t\t\t<\/a>\n\t\t\t\t\t\tCaps de grup\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Capell\u00e1 Munar, Gabriel<\/li>\n<li>L\u00e1zaro\u00a0 Garc\u00eda, Conxi<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es principals\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Pineda Riu, Marta<\/li>\n<li>Brunet Vidal, Joan Maria<\/li>\n<li>Valle Velasco, Laura<\/li>\n<li>Rivera Polo, Barbara<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es cl\u00ednics\/ques\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Teule Vega, Alexandre<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es postdoctorals\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Del Valle Dominguez, Jesus<\/li>\n<li>Morell Ginesta, Mireia<\/li>\n<li>Feliubadalo Elorza, Maria Lidia<\/li>\n<li>Fernandez Rodriguez, Juana<\/li>\n<li>Terradas Ill, Mariona<\/li>\n<li>Marin Nieto, Fatima<\/li>\n<li>Boni, Jacopo<\/li>\n<li>Brinco De Oliveira Ponte, Ana Filipa<\/li>\n<li>Climent Cant\u00f3, Paula<\/li>\n<li>Rofes Terr\u00f3n, Paula<\/li>\n<li>Mu\u00f1oz Miralles, Xavier<\/li>\n<li>Due\u00f1as Cid, N\u00faria<\/li>\n<li>Dominguez, Luciana Maria<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es predoctorals\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Creus Bachiller, Edgar<\/li>\n<li>Torralba Carnerero, Manuel<\/li>\n<li>Munte Roca, Elisabet<\/li>\n<li>Ortega Bertr\u00e1n, Sara<\/li>\n<li>\u00a0Roca Grau, Carla<\/li>\n<li>Chong, Anne Sophie<\/li>\n<li>Viana Errasti, Julen<\/li>\n<li>Nogue Anson, Clara<\/li>\n<li>Mesia Carbonell, Oscar<\/li>\n<li>Urdiales Santidrian, Diego<\/li>\n<li>Millan Castillo, Miriam<\/li>\n<\/ul>\n\t\t\t\t\t\tSuport cient\u00edfic\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Aiza Buscarons, Gemma<\/li>\n<li>Ramos Muntada, Mireia<\/li>\n<li>Rioja Llerena, Cristina<\/li>\n<li>Salvador Hernandez, Lluis<\/li>\n<li>Cuesta Llorente, Raquel<\/li>\n<li>Campos Mata, Olga<\/li>\n<li>Gomez Hernandez, Carolina<\/li>\n<li>\u00a0Montes Segura, Eva<\/li>\n<li>Campo Fernandez, Guillem<\/li>\n<li>Canet Hermida, Julia<\/li>\n<li>Fernandez Gonzalez, Miriam<\/li>\n<li>Galan Rueda, Marina<\/li>\n<\/ul>\n\t\t\t\t\t\tSuport de gesti\u00f3\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Rubio Carre, Iolanda<\/li>\n<li>Prada Dacasa, Patricia<\/li>\n<li>Torcal Garcia, Guillem<\/li>\n<\/ul>\n\t\t\t\t\t\tEstudiants\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>P\u00e9rez Chicharro, Llara<\/li>\n<\/ul>\n\t\t\t\t\t\tCol\u00b7laboradors\/es\n\t\t\t\t\t\t\t\t\t\t\t<ul>\n<li>Moreno Cabrera, Jose Marcos<\/li>\n<li>Antoli Gil, Arnau<\/li>\n<li>Gonz\u00e1lez Acosta, Mar\u00eda Isabel<\/li>\n<li>Menendez Vila, Mireia<\/li>\n<li>Azuara Garc\u00eda, Daniel<\/li>\n<li>Solanich Moreno, Xavier<\/li>\n<li>Torres Omedes, Noelia<\/li>\n<li>Losilla G\u00f3mez , Gemma<\/li>\n<li>Salinas Masdeu , M\u00f2nica<\/li>\n<li>Iglesias Casals, Silvia<\/li>\n<li>Solanes Cabus, Noemi Ares<\/li>\n<li>Castillo Manzano, Carmen<\/li>\n<li>Mart\u00edn Mestre, Marta Irene<\/li>\n<li>Berrocal G\u00f3mez, Laura<\/li>\n<li>Sierra Fortuny, Angels<\/li>\n<li>Gomez Vazquez, Jose Luis<\/li>\n<\/ul>\n<h2>\n\t\tNot\u00edcies relacionades\n\t<\/h2>\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/27160\" content=\"Un nou estudi estableix noves recomanacions per a l'estudi del gen TP53 relacionat amb el c\u00e0ncer hereditari\" \/><meta itemprop=\"datePublished\" content=\"2025-02-12\" \/><meta itemprop=\"dateModified\" content=\"2025-02-12\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2025\/02\/estudi-cancer-hereditari-NOTI.jpg\" \/><meta itemprop=\"width\" content=\"1365\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2025\/02\/un-nou-estudi-estableix-noves-recomanacions-per-a-lestudi-del-gen-tp53-relacionat-amb-el-cancer-hereditari\/\" title=\"Un nou estudi estableix noves recomanacions per a l'estudi del gen TP53 relacionat amb el c\u00e0ncer hereditari\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2025\/02\/un-nou-estudi-estableix-noves-recomanacions-per-a-lestudi-del-gen-tp53-relacionat-amb-el-cancer-hereditari\/\" title=\"Un nou estudi estableix noves recomanacions per a l'estudi del gen TP53 relacionat amb el c\u00e0ncer hereditari\">Un nou estudi estableix noves recomanacions per a l&#8217;estudi del gen TP53 relacionat amb el c\u00e0ncer hereditari<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t12\/02\/2025\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/27052\" content=\"Una nova triple combinaci\u00f3 d&#8217;inhibidors basada en medicina de precisi\u00f3 sorgeix com un possible tractament per als tumors malignes de la beina dels nervis perif\u00e8rics\" \/><meta itemprop=\"datePublished\" content=\"2025-01-28\" \/><meta itemprop=\"dateModified\" content=\"2025-01-28\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2025\/01\/Equip-cancer-hereditari-IDIBELL.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2025\/01\/una-nova-triple-combinacio-dinhibidors-basada-en-medicina-de-precisio-sorgeix-com-un-possible-tractament-per-als-tumors-malignes-de-la-beina-dels-nervis-periferics\/\" title=\"Una nova triple combinaci\u00f3 d&#8217;inhibidors basada en medicina de precisi\u00f3 sorgeix com un possible tractament per als tumors malignes de la beina dels nervis perif\u00e8rics\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2025\/01\/una-nova-triple-combinacio-dinhibidors-basada-en-medicina-de-precisio-sorgeix-com-un-possible-tractament-per-als-tumors-malignes-de-la-beina-dels-nervis-periferics\/\" title=\"Una nova triple combinaci\u00f3 d&#8217;inhibidors basada en medicina de precisi\u00f3 sorgeix com un possible tractament per als tumors malignes de la beina dels nervis perif\u00e8rics\">Una nova triple combinaci\u00f3 d&#8217;inhibidors basada en medicina de precisi\u00f3 sorgeix com un possible tractament per als tumors malignes de la beina dels nervis perif\u00e8rics<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t28\/01\/2025\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/26630\" content=\"La Marat\u00f3 de 3Cat finan\u00e7a tres projectes de l'IDIBELL en salut sexual i reproductiva\" \/><meta itemprop=\"datePublished\" content=\"2024-11-22\" \/><meta itemprop=\"dateModified\" content=\"2024-11-22\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2024\/11\/lliurament-02_lamarato-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1707\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/11\/la-marato-de-3cat-financa-tres-projectes-de-lidibell-en-salut-sexual-i-reproductiva\/\" title=\"La Marat\u00f3 de 3Cat finan\u00e7a tres projectes de l'IDIBELL en salut sexual i reproductiva\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/11\/la-marato-de-3cat-financa-tres-projectes-de-lidibell-en-salut-sexual-i-reproductiva\/\" title=\"La Marat\u00f3 de 3Cat finan\u00e7a tres projectes de l'IDIBELL en salut sexual i reproductiva\">La Marat\u00f3 de 3Cat finan\u00e7a tres projectes de l&#8217;IDIBELL en salut sexual i reproductiva<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t22\/11\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/26236\" content=\"SpadaHC, una nova base de dades per millorar la classificaci\u00f3 de variants en gens de c\u00e0ncer hereditari a la poblaci\u00f3 espanyola\" \/><meta itemprop=\"datePublished\" content=\"2024-09-02\" \/><meta itemprop=\"dateModified\" content=\"2024-09-03\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2024\/09\/NO081-Web.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/09\/spadahc-una-nova-base-de-dades-per-millorar-la-classificacio-de-variants-en-gens-de-cancer-hereditari-a-la-poblacio-espanyola\/\" title=\"SpadaHC, una nova base de dades per millorar la classificaci\u00f3 de variants en gens de c\u00e0ncer hereditari a la poblaci\u00f3 espanyola\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/09\/spadahc-una-nova-base-de-dades-per-millorar-la-classificacio-de-variants-en-gens-de-cancer-hereditari-a-la-poblacio-espanyola\/\" title=\"SpadaHC, una nova base de dades per millorar la classificaci\u00f3 de variants en gens de c\u00e0ncer hereditari a la poblaci\u00f3 espanyola\">SpadaHC, una nova base de dades per millorar la classificaci\u00f3 de variants en gens de c\u00e0ncer hereditari a la poblaci\u00f3 espanyola<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t02\/09\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/26123\" content=\"Un nou algoritme bioinform\u00e0tic millora la detecci\u00f3 gen\u00e8tica de les s\u00edndrome de Lynch i CMMRD\" \/><meta itemprop=\"datePublished\" content=\"2024-07-12\" \/><meta itemprop=\"dateModified\" content=\"2024-07-12\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2024\/07\/20240701_115124-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1440\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/07\/un-nou-algoritme-bioinformatic-millora-la-deteccio-genetica-de-les-sindrome-de-lynch-i-cmmrd\/\" title=\"Un nou algoritme bioinform\u00e0tic millora la detecci\u00f3 gen\u00e8tica de les s\u00edndrome de Lynch i CMMRD\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/07\/un-nou-algoritme-bioinformatic-millora-la-deteccio-genetica-de-les-sindrome-de-lynch-i-cmmrd\/\" title=\"Un nou algoritme bioinform\u00e0tic millora la detecci\u00f3 gen\u00e8tica de les s\u00edndrome de Lynch i CMMRD\">Un nou algoritme bioinform\u00e0tic millora la detecci\u00f3 gen\u00e8tica de les s\u00edndrome de Lynch i CMMRD<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t12\/07\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/26096\" content=\"Un test gen\u00e8tic permetr\u00e0 millorar el diagn\u00f2stic d'una s\u00edndrome minorit\u00e0ria de predisposici\u00f3 al c\u00e0ncer en nens\" \/><meta itemprop=\"datePublished\" content=\"2024-07-04\" \/><meta itemprop=\"dateModified\" content=\"2024-07-04\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2024\/07\/NP-IDIBELL-CMMRD-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1440\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/07\/un-test-genetic-permetra-millorar-el-diagnostic-duna-sindrome-minoritaria-de-predisposicio-al-cancer-en-nens\/\" title=\"Un test gen\u00e8tic permetr\u00e0 millorar el diagn\u00f2stic d'una s\u00edndrome minorit\u00e0ria de predisposici\u00f3 al c\u00e0ncer en nens\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/07\/un-test-genetic-permetra-millorar-el-diagnostic-duna-sindrome-minoritaria-de-predisposicio-al-cancer-en-nens\/\" title=\"Un test gen\u00e8tic permetr\u00e0 millorar el diagn\u00f2stic d'una s\u00edndrome minorit\u00e0ria de predisposici\u00f3 al c\u00e0ncer en nens\">Un test gen\u00e8tic permetr\u00e0 millorar el diagn\u00f2stic d&#8217;una s\u00edndrome minorit\u00e0ria de predisposici\u00f3 al c\u00e0ncer en nens<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t04\/07\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/25188\" content=\"L'Associaci\u00f3 Contra el C\u00e0ncer a Barcelona finan\u00e7a dos projectes de l'IDIBELL amb 445.000 euros\" \/><meta itemprop=\"datePublished\" content=\"2024-03-07\" \/><meta itemprop=\"dateModified\" content=\"2024-03-08\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2024\/03\/NO020-AECC.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/03\/lassociacio-contra-el-cancer-a-barcelona-financa-dos-projectes-de-lidibell-amb-445-000-euros\/\" title=\"L'Associaci\u00f3 Contra el C\u00e0ncer a Barcelona finan\u00e7a dos projectes de l'IDIBELL amb 445.000 euros\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/03\/lassociacio-contra-el-cancer-a-barcelona-financa-dos-projectes-de-lidibell-amb-445-000-euros\/\" title=\"L'Associaci\u00f3 Contra el C\u00e0ncer a Barcelona finan\u00e7a dos projectes de l'IDIBELL amb 445.000 euros\">L&#8217;Associaci\u00f3 Contra el C\u00e0ncer a Barcelona finan\u00e7a dos projectes de l&#8217;IDIBELL amb 445.000 euros<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t07\/03\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/24810\" content=\"Troben com definir ter\u00e0pies dirigides en c\u00e0ncer de pulm\u00f3 gr\u00e0cies a una plataforma de seq\u00fcenciaci\u00f3 gen\u00e8tica\" \/><meta itemprop=\"datePublished\" content=\"2024-01-04\" \/><meta itemprop=\"dateModified\" content=\"2024-01-04\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2024\/01\/231219-Conxi-Ernest-002.jpg\" \/><meta itemprop=\"width\" content=\"1366\" \/><meta itemprop=\"height\" content=\"768\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/01\/troben-com-definir-terapies-dirigides-en-cancer-de-pulmo-gracies-a-una-plataforma-de-sequenciacio-genetica\/\" title=\"Troben com definir ter\u00e0pies dirigides en c\u00e0ncer de pulm\u00f3 gr\u00e0cies a una plataforma de seq\u00fcenciaci\u00f3 gen\u00e8tica\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2024\/01\/troben-com-definir-terapies-dirigides-en-cancer-de-pulmo-gracies-a-una-plataforma-de-sequenciacio-genetica\/\" title=\"Troben com definir ter\u00e0pies dirigides en c\u00e0ncer de pulm\u00f3 gr\u00e0cies a una plataforma de seq\u00fcenciaci\u00f3 gen\u00e8tica\">Troben com definir ter\u00e0pies dirigides en c\u00e0ncer de pulm\u00f3 gr\u00e0cies a una plataforma de seq\u00fcenciaci\u00f3 gen\u00e8tica<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t04\/01\/2024\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/24617\" content=\"Un estudi de l'IDIBELL, l'ICO i l'IGTP posa la medicina de precisi\u00f3 al servei dels tumors nerviosos\" \/><meta itemprop=\"datePublished\" content=\"2023-11-23\" \/><meta itemprop=\"dateModified\" content=\"2023-11-23\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/11\/Lazaro-Villanueva-scaled.jpg\" \/><meta itemprop=\"width\" content=\"2560\" \/><meta itemprop=\"height\" content=\"1280\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/11\/un-estudi-de-lidibell-lico-i-ligtp-posa-la-medicina-de-precisio-al-servei-dels-tumors-nerviosos\/\" title=\"Un estudi de l'IDIBELL, l'ICO i l'IGTP posa la medicina de precisi\u00f3 al servei dels tumors nerviosos\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/11\/un-estudi-de-lidibell-lico-i-ligtp-posa-la-medicina-de-precisio-al-servei-dels-tumors-nerviosos\/\" title=\"Un estudi de l'IDIBELL, l'ICO i l'IGTP posa la medicina de precisi\u00f3 al servei dels tumors nerviosos\">Un estudi de l&#8217;IDIBELL, l&#8217;ICO i l&#8217;IGTP posa la medicina de precisi\u00f3 al servei dels tumors nerviosos<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t23\/11\/2023\t\t\t\t\t\t\t\n\t<meta itemscope itemprop=\"mainEntityOfPage\" itemtype=\"https:\/\/schema.org\/WebPage\" itemid=\"http:\/\/24335\" content=\"Noves recomanacions per a la classificaci\u00f3 de variants en els gens POLE i POLD1 per millorar la precisi\u00f3 diagn\u00f2stica en c\u00e0ncer hereditari\" \/><meta itemprop=\"datePublished\" content=\"2023-10-25\" \/><meta itemprop=\"dateModified\" content=\"2023-10-25\" \/><meta itemprop=\"name\" content=\"IDIBELL\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/03\/cropped-Marca-B.png\"\/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/author\/comunicacio\/\" \/><meta itemprop=\"name\" content=\"comunicacio\" \/><meta itemprop=\"url\" content=\"https:\/\/idibell.cat\/wp-content\/uploads\/2023\/10\/Laura-Valle-Pilar-Mur.jpeg\" \/><meta itemprop=\"width\" content=\"1024\" \/><meta itemprop=\"height\" content=\"512\" \/><meta itemprop=\"interactionType\" content=\"https:\/\/schema.org\/CommentAction\" \/><meta itemprop=\"userInteractionCount\" content=\"0\" \/>\t\n\t\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/10\/noves-recomanacions-per-a-la-classificacio-de-variants-en-els-gens-pole-i-pold1-per-millorar-la-precisio-diagnostica-en-cancer-hereditari\/\" title=\"Noves recomanacions per a la classificaci\u00f3 de variants en els gens POLE i POLD1 per millorar la precisi\u00f3 diagn\u00f2stica en c\u00e0ncer hereditari\"><\/a>\n\t\t\t<a href=\"https:\/\/idibell.cat\/2023\/10\/noves-recomanacions-per-a-la-classificacio-de-variants-en-els-gens-pole-i-pold1-per-millorar-la-precisio-diagnostica-en-cancer-hereditari\/\" title=\"Noves recomanacions per a la classificaci\u00f3 de variants en els gens POLE i POLD1 per millorar la precisi\u00f3 diagn\u00f2stica en c\u00e0ncer hereditari\">Noves recomanacions per a la classificaci\u00f3 de variants en els gens POLE i POLD1 per millorar la precisi\u00f3 diagn\u00f2stica en c\u00e0ncer hereditari<\/a>\n\t\t\tBy <a href=\"https:\/\/idibell.cat\/author\/comunicacio\/\">comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t  |  \n\t\t\t\t\t\t\t\t\t25\/10\/2023\t\t\t\t\t\t\t\n\t\t<!-- .pp-content-posts -->\n\n","protected":false},"excerpt":{"rendered":"<p>C\u00e0ncer hereditari Resum Som un grup de recerca multidisciplinar que treballa en C\u00e0ncer Hereditari a l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, Institut de Recerca Biom\u00e8dica de Bellvitge (IDIBELL) i l&#8217;Institut de Recerca en Ci\u00e8ncies de la Salut Germans Trias i Pujol (IGTP). La nostra feina, ja sigui cl\u00ednica o de recerca, se centra en la millora de l&#8217;atenci\u00f3 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":448,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-1835","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2025-03-01 06:50:26","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/1835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=1835"}],"version-history":[{"count":13,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/1835\/revisions"}],"predecessor-version":[{"id":27257,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/1835\/revisions\/27257"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/448"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=1835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}